200758

Role of immunohistochemical expression of Leucine-rich Repeat- containing G5 (LGR5) as a stem cell marker in oral squamous cell carcinomas

Article

Last updated: 05 Jan 2025

Subjects

-

Tags

-

Abstract

The discovery of cancer stem cells (CSCs) has heralded an exciting era in our understanding of squamous cell carcinoma (SCC) with significant implications for diagnosis, prognosis, treatment, and ultimately patient outcomes. LGR5, a CSC-related protein, is targeted by the Wnt-signaling pathway. This study investigated the correlations between the available clinicopathological features of oral SCC and the immunohistochemical expression of LGR-5. The results of this study were LGR5 was expressed in all clinical stages as well as all histological grades of the studied cases with different extents. Statistical analysis revealed significant difference between all clinical stages as well as between all histological types of oral SCC (OSCC) cases in relation to the expression of LGR5. In addition, Spearman's correlation test found highly significant positive correlation between clinical stages and histological grades of studied cases on one hand and expression of LGR5 on the other hand. From these findings, we can conclude that LGR5 might play a role in SCC progression and could be considered as a prognostic indicator in OSCC.   Keywords:LGR5, CSCs, OSCC  

DOI

10.21608/mjd.2014.200758

Volume

1

Article Issue

1

Related Issue

28316

Issue Date

2014-01-01

Receive Date

2021-10-23

Publish Date

2014-01-01

Page Start

8

Page End

14

Print ISSN

2735-4172

Online ISSN

2812-5479

Link

https://mjd.journals.ekb.eg/article_200758.html

Detail API

https://mjd.journals.ekb.eg/service?article_code=200758

Order

2

Type

Original Article

Type Code

1,715

Publication Type

Journal

Publication Title

Mansoura Journal of Dentistry

Publication Link

https://mjd.journals.ekb.eg/

MainTitle

Role of immunohistochemical expression of Leucine-rich Repeat- containing G5 (LGR5) as a stem cell marker in oral squamous cell carcinomas

Details

Type

Article

Created At

23 Jan 2023